Subscribe
INDIAN SCENARIO

Andhra Pradesh MedTech Zone (AMTZ) to Develop Artificial Organs through 3D Bioprinting

3 Mins read
Andhra Pradesh MedTech Zone
Above: Dignitaries at the inauguration of the 3D Bioprinting Facility at AMTZ/Image Source: think3D

Sensing the impact of 3D printing on the healthcare sector and the future implications of the technology, the Andhra Pradesh MedTech Zone (AMTZ), on the 8th of March, 2021, inaugurated its 3D Bioprinting facility to develop artificial organs through 3D Bioprinting under the Bio Harmonised Aids for Rehabilitation and Treatment (BHARAT) programme to boost diagnostics and therapy.

The Andhra Pradesh MedTech Zone is India’s first medical device park is a flagship project of the Government of Andhra Pradesh to manufacture indigenous medical technology products in the country and make healthcare accessible to the common man. One of the highlight companies of the MedTech zone is think3D, one of India’s largest 3D printing service providers. Think3D has a 17,500 square feet facility in the AMTZ that focuses primarily on medical devices but also serves many other sectors including aerospace, maritime, automotive, architecture, prototyping, etc.

3D Bioprinting facility
Above: The 3D Bioprinting facility inaugurated at AMTZ/Image Source: Think3D

3D printing is an innovative technology that encompasses all medical disciplines and offers new opportunities in diagnostics and therapy. From diagnostic visualization to surgical planning patient-specific models will provide an added value for patients and physicians as part of the initiative.

The inauguration was attended by eminent guests like Dr. Jitendra Sharma(MD& CEO, AMTZ), Miss Mohini (Scientist B at BioValley Incubation Council, AMTZ), Raja Sekhar Upputuri (Co-founder &CEO, think3D, AMTZ), P  S Chandranand (CEO, Biovalley InCubation Council, AMTZ) Anand Krishnan (CEO, Medivalley Incubation Centre, AMTZ) Ms Sangeetha (Production Manager, DNA Xperts Pvt Ltd, AMTZ )

[penci_related_posts taxonomies=”undefined” title=”Related Posts” background=”” border=”Blue” thumbright=”yes” number=”4″ style=”grid” align=”none” displayby=”tag” orderby=”random”]

3D Bioprinters at Andhra Pradesh MedTech Zone

3D Bioprinter
Above: 3D Bioplotter from EnvisionTec/Image Source: EnvisionTec

The Andhra Pradesh MedTech Zone 3D bioprinting facility currently consists of two bioprinters; namely the 3D Bioplotter from EnvisionTec and another one from the University of Wollongong (UOW). As a part of a strategic collaboration between the University of Wollongong and ZMTZ, the ARC Centre of Excellence for Electromaterials Science (ACES) researchers supplied AMTZ with its Bioprinter. It is said that the Prosthetists in India connected with AMT will work on correcting ear deformities.

The UOW delivered its 3D Genii bioprinter which is designed and developed to print implantable, flexible, customised prosthetic ears that match the anatomy of patients suffering from microtia (a congenital deformity of the ear that has a heightened rate of disease in India compared to Australia).

The printer has been built specifically to deliver high precision silicon rubber prints in complex shapes, such as those found in an ear. The patient’s ear is scanned using smartphone software, and the file is uploaded for printing.

The 3D Genii will allow a prosthetist to complete their work faster and in a more streamlined manner, while providing simple scanning technology that can be used remotely to ensure the system is more accessible across the broader population.

3D Bioprinting
Above: (L to R) University of Wollongong researchers Sepehr Talebian and Dr. Sepidar Sayyar showing the ear prosthetics/Image Source: University of Wollongong

According to ACES Director, Distinguished Professor Gordon Wallace AO, “The delivery of printers to India is an exciting step in accelerating new technologies, creating new industries and building local medtech infrastructure for both Australia and India. We’ve seen some impressive advances in the partnership between UOW and Andhra Pradesh MedTech Zone in terms of identifying areas of clinical need, developing the best strategies to meet that need, and bringing together the knowledge and expertise to deliver the most effective solution in the least amount of time.”

Professor Wallace added, “Both India and Australia have challenges in delivering health innovations to their rural areas. We hope these latest developments will help in reaching out to those patients and healthcare professionals who can work remotely with us to access 3D printing technologies.”

The project also received support from the Federal Government’s Australia-India Council (AIC), to build bilateral partnerships to translate 3D bioprinting research in India, and is led in collaboration with RPA Ear, Nose and Throat Surgeon Associate Professor Payal Mukherjee.


About Manufactur3D: Manufactur3D is an online magazine on 3D Printing. Visit our Indian Scenario page for more updates on 3D Printing News from India. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on LinkedIn and Twitter.

2017 posts

About author
Manufactur3D is an Indian Online 3D Printing Media Platform that reports on the latest news, insights and analysis from the Indian and the Global 3D Printing Industry.
Articles
Related posts
INDIAN SCENARIO

Wipro 3D and Nikon SLM Solutions Partner to accelerate adoption of Additive Manufacturing in India

2 Mins read
Wipro 3D and Nikon SLM Solutions have announced a strategic partnership to accelerate the adoption of additive manufacturing in India.
INDIAN SCENARIO

Tvasta inaugurates Concrete 3D Printing Research Lab at Saintgits College

2 Mins read
Tvasta Manufacturing Solutions has established Kerala’s first Concrete 3D Printing Research Lab in collaboration with Saintgits College of
TECH NEWS

Stratasys updates Industrial and Healthcare Business Unit products and Stratasys Direct

2 Mins read
Stratasys announced improvements to many Industrial and Healthcare Business Unit products, as well as Stratasys Direct. The company has